C.M. Bidwell & Associates’s Exelixis EXEL Stock Holding History

C.M. Bidwell & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79K	Hold	1,452	–	–	0.03%	195
2026 Q1	$62.3K	Buy	+1,452	New	+$62.4K	0.03%	206
2023 Q4	–	Sell	-7,216	Closed	-$158K	–	524
2023 Q3	$158K	Buy	+7,216	New	+$151K	0.12%	147
2021 Q4	–	Sell	-10,875	Closed	-$230K	–	574
2021 Q3	$230K	Buy	+10,875	New	+$202K	0.15%	122
2018 Q1	–	Sell	-9,805	Closed	-$298K	–	400
2017 Q4	$298K	Sell	9,805 -7,670	-44%	-$204K	0.26%	109
2017 Q3	$423K	Buy	+17,475	New	+$465K	0.65%	44

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

C.M. Bidwell & Associates's EXEL Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Exelixis (EXEL) position steady in Q2 2026 at 1,452 shares worth $79K. The position accounts for 0.03% of the portfolio, ranked #195.

C.M. Bidwell & Associates first reported a position in EXEL in Q3 2017 and has held it in 6 quarters since. The position peaked at $423K in Q3 2017. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

C.M. Bidwell & Associates held 1,452 shares of Exelixis worth $79K as of Q2 2026.
C.M. Bidwell & Associates left its Exelixis share count unchanged in Q2 2026.
Exelixis made up 0.03% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #195 holding.
C.M. Bidwell & Associates first reported a position in Exelixis in Q3 2017 and has held it in 6 quarters since.
C.M. Bidwell & Associates's Exelixis position peaked at $423K in Q3 2017.
758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.